Philip Morris, Medicago To Develop Flu Vaccines From Tobacco For China
This article was originally published in PharmAsia News
Executive Summary
Drug makers making and marketing their wares in China are getting a potential new competitor, U.S. cigarette-maker Philip Morris International and its aim to use tobacco to develop influenza vaccines.